Cargando…
Efficacy and Safety of Intravenous rtPA in Ischemic Strokes Due to Small-Vessel Occlusion: Systematic Review and Meta-Analysis
Intravenous recombinant tissue plasminogen activator (iv-rtPA) has been routinely used to treat ischemic stroke for 25 years, following large clinical trials. However, there are few prospective studies on the efficacy and safety of this therapy in strokes attributed to cerebral small vessel disease...
Autores principales: | Karaszewski, Bartosz, Wyszomirski, Adam, Jabłoński, Bartosz, Werring, David J., Tomaka, Dominika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055574/ https://www.ncbi.nlm.nih.gov/pubmed/33641037 http://dx.doi.org/10.1007/s12975-021-00890-9 |
Ejemplares similares
-
SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
por: Karaszewski, Bartosz, et al.
Publicado: (2021) -
Case report: First treatment of acute ischaemic stroke in a patient on active rivaroxaban therapy using andexanet alfa and rtPA combined with early complete recovery
por: Karaszewski, Bartosz, et al.
Publicado: (2023) -
Meta-analysis of Vascular Imaging Features to Predict Outcome Following Intravenous rtPA for Acute Ischemic Stroke
por: Nogueira, Ricardo C., et al.
Publicado: (2016) -
Intravenous rtPA versus mechanical thrombectomy in acute ischemic stroke: A historical cohort in Joinville, Brazil
por: Cabral, Norberto L., et al.
Publicado: (2016) -
New Remote Cerebral Microbleeds on T2(*)-Weighted Echo Planar MRI After Intravenous Thrombolysis for Acute Ischemic Stroke
por: Jabłoński, Bartosz, et al.
Publicado: (2022)